ISGyP LiVE Webinar – Problem Areas in the Diagnosis of Uterine Smooth Muscle Tumors. Dr. Esther Oliva
Inaugural event for the ISGyP LiVE educational series
Loading view.
E. Uterine mesenchymal
ISGyP LiVE Slide Session – Uterine mesenchymal tumors with deceptively bland morphology. Dr. Joseph Rabban
Actual glass slides of cases will be presented with opportunities for audience questions. You may preview a few of the digital slides at this site: https://pathology.ucsf.edu/cases-isgyp-live-slide-session-sept-3-2020
ISGyP LiVE Journal Club – Uterine mesenchymal tumors
Dr. Natalie Banet moderates the discussion of studies pertinent to the practice of Gynecological Pathology, led by pathology trainees. Articles to be presented: Croce S, Hostein I, Longacre TA, et al. Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion […]
ISGyP LiVE Podcast – Pathologic classification of vulvovaginal and adnexal smooth muscle tumors. Dr. Sadia Sayeed and Dr. Vatsal Patel
Drs. Sayeed and Patel discuss their recent studies on the classification of smooth muscle neoplasms of the vulvovaginal region and the adnexa (https://pubmed.ncbi.nlm.nih.gov/28786880/; https://pubmed.ncbi.nlm.nih.gov/30702465/).
ISGYP Podcast – IHC biomarkers in uterine smooth muscle tumors. Dr. Kianoosh Keyhanian
We chat we Dr. Kianoosh Keyhanian about her previous work on immunohistochemical biomarker testing in benign, malignant and intermediate smooth muscle tumors of the uterus. Article: https://pubmed.ncbi.nlm.nih.gov/32515921/
ISGyP LiVE Journal Club – Mesenchymal lesions, Uterus
Zoom webinarThe presenters and articles are: Linda Logan (US) presenting: Chapel et al. Epithelioid Leiomyosarcoma of the Uterus: Modern Outcome-based Appraisal of Diagnostic Criteria in a Large Institutional Series. Am J Surg Pathol. 2022 Apr 1;46(4):464-475. PMID: 38418687. Desmond Lim (NZ) presenting: Ladwig et al. Uterine Inflammatory Myofibroblastic Tumors Proposed Risk Stratification Model Using Integrated Clinicopathologic […]
